Telehealth General Psychiatry Prescribing: What PMHNPs Can Do in New York

You’re a psychiatrist or psychiatric nurse practitioner considering telehealth, and the first question that hits you is probably: Can I actually prescribe medications remotely? What about controlled substances like Adderall or Xanax? Will I get paid the same as in-person visits?

The short answer: Yes, psychiatrists can prescribe nearly all psychiatric medications via telehealth in 2026 — including controlled substances for ADHD, anxiety, and other conditions — thanks to federal waivers and state law changes. But the details matter, especially if you’re a PMHNP or practicing across multiple states.

This guide breaks down exactly what psychiatrists and PMHNPs can prescribe through telemedicine, how state laws differ (particularly in California, Texas, Florida, New York, Pennsylvania, and Illinois), what collaborative agreements actually require, and how reimbursement stacks up. No fluff — just what you need to know to practice legally and get paid fairly.

What Can Psychiatrists Actually Prescribe via Telehealth?

The Bottom Line for Psychiatrists (MD/DO):
As a fully licensed physician, you can prescribe any psychiatric medication — antidepressants, antipsychotics, mood stabilizers, stimulants, benzodiazepines, buprenorphine — through a secure video visit, provided you establish a valid patient-physician relationship. This includes Schedule II controlled substances like Adderall or Ritalin for ADHD.

Federal Rules: The Ryan Haight Act and COVID Waivers

Normally, the Ryan Haight Act requires an in-person medical evaluation before prescribing controlled substances (Schedules II-V). But since March 2020, the DEA has waived this requirement under public health emergency powers. As of early 2026, this telemedicine flexibility remains in effect — extended through December 31, 2025, and likely to be extended again given the political and practical realities of mental healthcare access.

What this means practically: You can conduct a thorough psychiatric evaluation via video, diagnose ADHD or anxiety, and prescribe a 30-day supply of a stimulant or benzodiazepine without ever seeing the patient in person. The evaluation must meet the standard of care — real-time audio-visual interaction that allows you to assess mental status, rule out contraindications, and document appropriately.

The catch: The DEA has proposed permanent rules that could reinstate some in-person requirements (like a 30-day supply limit before requiring an in-person visit, or allowing only if another provider saw the patient face-to-face). These rules have been in limbo since 2023. For now, the temporary waiver holds. Monitor DEA announcements — if rules tighten, you may need to adjust your practice (likely by scheduling an annual in-person check-in or referring new controlled-substance patients to a local provider for initial exam).

State-Level Telehealth Prescribing Rules

While federal law sets the controlled-substance baseline, states can add their own restrictions. The good news: most states explicitly allow psychiatric prescribing via telehealth, often with mental health carve-outs that are more permissive than other specialties.

Key State Examples:

• Florida: Florida law explicitly permits controlled substance prescribing via telehealth for psychiatric treatment. Florida Statute 456.47 allows teleprescribing of controlled meds for mental disorders, inpatient care, hospice, etc. — but prohibits it for chronic pain management. Translation: you can prescribe Adderall for ADHD or Ativan for panic disorder via video in Florida, no problem. This is one of the most telehealth-friendly states for psychiatry.

• Texas: Texas allows telemedicine prescribing if the standard of care is met (audio-visual consult). However, Texas prohibits prescribing Schedule II opioids for chronic pain via telehealth — you’d need an in-person exam. Mental health treatment is exempt from this restriction, so prescribing stimulants or benzodiazepines for psychiatric conditions is allowed under the federal waiver. Texas does require you to check the state Prescription Monitoring Program (PMP) before prescribing any controlled substance.

• New York: New York recently finalized regulations (mid-2025) that align state law with federal DEA allowances. Previously, NY technically required an in-person exam for controlled substances, but emergency orders suspended this. The new rule codifies that psychiatrists can prescribe controlled substances via telehealth when consistent with federal law — meaning as long as the DEA waiver is active, you’re clear to prescribe. New York also mandates e-prescribing (no paper scripts) and checking the state PMP (I-STOP registry).

• California: California does not require in-person exams for prescribing via telehealth. The state’s ‘good faith exam’ standard can be met through a video consultation. California defers to federal law on controlled substances; during the DEA waiver period, CA psychiatrists have been prescribing stimulants and other controlled meds remotely. You must enroll in CURES (California’s PMP) and check it before prescribing Schedule II-IV drugs.

• Pennsylvania and Illinois: Both states have no unique state-level bans on teleprescribing controlled substances for mental health. As long as federal law allows it (which it does under the current waiver), you can prescribe. Illinois requires checking the state PMP; Pennsylvania requires appropriate documentation and consent.

Practical takeaway: In 2026, psychiatrists licensed in these states can initiate and manage psychiatric medications — including controlled substances — entirely via telehealth. Just ensure you:

• Use a HIPAA-compliant video platform (audio-visual required for initial controlled substance prescriptions)
• Document the evaluation thoroughly (mental status exam, diagnosis, treatment plan)
• Check the state prescription monitoring database before prescribing controlled meds
• Obtain informed consent for telehealth treatment
• Have an emergency protocol if a patient is in crisis during a remote session

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs. Psychiatrist Prescribing Authority: Who Can Do What?

This is where things get messy. Psychiatrists have full prescriptive authority in all 50 states. Psychiatric Nurse Practitioners? It depends entirely on where they’re licensed.

The Three Categories of NP Scope of Practice

States fall into three buckets when it comes to NP independence:

1. Full Practice Authority (FPA) States
NPs can evaluate, diagnose, and prescribe independently — no physician oversight required. As of 2025, roughly 34 states grant FPA to experienced NPs. Examples: Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, Massachusetts, Kansas, Indiana, Louisiana, Michigan.

In these states, a PMHNP can open their own practice, prescribe any medication within their scope (including Schedule II stimulants), and bill under their own NPI. They need their own DEA license for controlled substances.

2. Reduced Practice/Transitional States
NPs need a collaborative agreement with a physician, at least initially. Many of these states have a transition-to-independence pathway where NPs can eventually practice autonomously after accumulating supervised hours.

• New York: NPs must complete 3,600 hours (about 2 years) under a collaborative agreement. After that, they practice independently — no physician supervision, no chart co-signing. They must attest to having an informal ‘collaborative relationship’ (essentially a referral network), but it’s not binding.

• Illinois: NPs need 4,000 hours of collaboration plus 250 hours of continuing education. After meeting these requirements, they can apply for Full Practice Authority and prescribe independently. Until then, all prescriptions must be under physician delegation (physician’s name on the script).

• California: Historically required physician ‘standardized procedures.’ But AB 890 (2020) created a pathway to independence. As of 2023, NPs with 3+ years of experience can become ‘103 NPs’ and practice in collaborative settings (like group practices) without direct supervision. By January 2026, they can become ‘104 NPs’ and practice fully independently, even solo. New graduate NPs still need physician oversight for their first 3 years.

3. Restricted Practice States
NPs must have continuous physician supervision or delegation — no pathway to independence, regardless of experience.

• Texas: All NPs must have a Prescriptive Authority Agreement with a Texas physician to prescribe anything. The physician doesn’t need to be on-site, but must have regular meetings with the NP (monthly for the first 3 years, then quarterly). Texas also limits physicians to supervising no more than 7 NPs at once. Critical restriction: Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (with very narrow exceptions like terminal illness). This means most Texas PMHNPs rely on a supervising psychiatrist to write initial stimulant prescriptions for ADHD patients.

• Florida: Florida created ‘Autonomous APRN’ status in 2020, but psychiatric NPs were excluded. Only primary care NPs (family medicine, internal medicine, pediatrics) can practice independently. PMHNPs must have a supervising physician — typically a psychiatrist if they want to prescribe psychotropic controlled substances. Florida does allow psychiatric NPs to prescribe Schedule II meds for mental health treatment (no 7-day limit like other NPs have for opioids), but only under a collaborative protocol with a psychiatrist.

• Pennsylvania: NPs must have a collaborative agreement indefinitely — no FPA pathway yet (though legislation has been introduced). The agreement must specify which drugs the NP can prescribe. Pennsylvania requires physician co-signature or review of a certain percentage of NP charts, and NPs prescribing Schedule II drugs must notify the physician within 24 hours and limit initial scripts to 30 days.

What This Means for Telehealth Practices

If you’re a psychiatrist, you can practice independently in any state where you hold a license. If you want to treat patients in multiple states, get licensed in each state (or use the Interstate Medical Licensure Compact if applicable — TX, PA, and IL are members; NY, FL, and CA are not).

If you’re a PMHNP, your ability to prescribe independently via telehealth depends on:

1. The patient’s state laws (not your home state)
2. Your collaborative agreement (if required)
3. Whether you’ve met transition requirements (hours, CE) for states with FPA pathways

Example: A PMHNP licensed in New York with 5 years of experience (past the 3,600-hour mark) can prescribe independently to NY patients via telehealth. But if that same NP gets licensed in Texas, they’d need to establish a Prescriptive Authority Agreement with a Texas physician to prescribe to Texas patients — even though they’re independent in NY.

This creates headaches for telehealth platforms trying to scale. Many companies solve this by either:

• Only operating in FPA states for NPs
• Employing both psychiatrists and NPs, with psychiatrists supervising NPs in restricted states
• Partnering with physician groups to provide collaborative agreements for NPs

Cost of collaboration: Finding a collaborating psychiatrist in restricted states can be expensive — some physicians charge $1,000-$3,000/month for supervision, chart review, and signing agreements. This eats into an NP’s income and limits autonomy.

Collaborative Practice Agreements: What’s Actually Required?

If you’re a PMHNP in a reduced or restricted state, understanding collaborative practice agreements (CPAs) is critical. Here’s what they typically include:

Scope Definition: The agreement must list what the NP can do — diagnose and treat which conditions, prescribe which medications. For psychiatric NPs, this usually means full authority to prescribe psychiatric medications (antidepressants, antipsychotics, mood stabilizers, anxiolytics, stimulants), but may exclude certain classes (e.g., some agreements prohibit NPs from prescribing buprenorphine for opioid use disorder, or MAO inhibitors, unless specifically authorized).

Physician Availability: The collaborating physician must be available for consultation — typically by phone or secure messaging. Some states require the agreement to specify response times (e.g., physician will respond within 2 hours during business hours).

Chart Review: Many states mandate that the physician review a percentage of the NP’s patient charts. Common requirement: 10% of charts reviewed quarterly or monthly. In Texas, the law requires periodic quality assurance meetings to review cases. In Pennsylvania, physicians must review a portion of charts (especially for Schedule II prescriptions) and meet with the NP at least twice a year.

Prescribing Limits: The agreement may cap what the NP can prescribe. For example:

• Florida: If the NP is not a designated ‘psychiatric nurse’ (PMHNP with 2+ years under a psychiatrist), they can’t prescribe psychotropic controlled substances. Even designated psychiatric NPs must collaborate with a psychiatrist to prescribe those meds.
• Texas: The agreement must explicitly delegate controlled substance prescribing. Schedule II prescriptions (stimulants) are generally prohibited for NPs in outpatient settings unless under very narrow circumstances.
• Pennsylvania: Schedule II prescriptions by NPs are limited to 30-day supply, and the physician must be notified within 24 hours.

Filing Requirements: Some states require the CPA to be filed with the state nursing or medical board (e.g., Kentucky requires filing controlled-substance collaboration agreements). Others just require it be maintained on-site and available for inspection.

Geographic Restrictions: A few states require the collaborating physician to be licensed in the same state as the NP (though many now allow remote collaboration). Some states also limit how many NPs one physician can supervise — Texas caps it at 7 NPs/PAs per physician.

Practical Impact: These requirements mean PMHNPs in restricted states often:

• Work for large healthcare systems or telehealth companies that provide the collaborating physician as part of the employment package
• Pay out-of-pocket for collaboration (cutting into income)
• Face delays in starting practice if they can’t find a collaborating psychiatrist (especially in underserved areas where psychiatrists are scarce)
• Have less clinical autonomy — even though they’re trained to manage complex cases, they may need physician approval for certain medication decisions

The trend: More states are moving toward FPA to address provider shortages. Since 2020, over a dozen states have granted NPs independence. But as of 2026, large states like Texas, Florida, and Pennsylvania still require collaboration for PMHNPs, creating a two-tiered system where an experienced NP has full authority in one state but needs supervision in another.

How Reimbursement Works: Will You Get Paid the Same for Telehealth?

The short answer: Yes, for psychiatry. Telehealth reimbursement for mental health services has reached near-parity with in-person visits, especially post-pandemic.

Medicare Reimbursement

Medicare has permanently expanded telehealth for mental health services. You can bill standard E/M codes (99213, 99214, etc.) for video visits and get paid the same as in-person.

2026 Medicare rates (national average):

• 90792 (initial psychiatric evaluation with med services): ~$173
• 99213 (15-minute follow-up, low-moderate complexity): ~$95
• 99214 (25-minute follow-up, moderate-high complexity): ~$136
• 99215 (40-minute visit, high complexity): ~$192

These rates apply to telehealth visits. Use place of service (POS) code 02 or 10 (depending on originating site rules) or modifier -95 for telehealth.

For PMHNPs: Medicare pays NPs at 85% of the physician fee schedule when billed under the NP’s own NPI. So a 99213 would pay an NP around $81 instead of $95. Many practices mitigate this by having the NP’s services billed ‘incident to’ a physician (100% reimbursement), but this requires the physician to be on-site — not feasible for telehealth.

Audio-only telehealth: Medicare has also extended coverage for audio-only mental health services (phone calls) through 2025, recognizing the digital divide. If a patient can’t access video, you can conduct a phone med check and bill the same E/M code. This is a huge win for access.

Private Insurance

Commercial insurers generally follow Medicare’s lead. Many pay equal or higher rates for telehealth mental health services.

State parity laws help here:

• Illinois (SB 667, 2021): Requires private insurers to reimburse telehealth at parity through at least 2027.
• California (AB 744, 2019): Mandates payment parity for telehealth services.
• New York: Updated its telehealth law in 2021 to ensure coverage and reimbursement for tele-mental health.
• Texas: Has telehealth coverage requirements but no mandated payment parity — though most insurers voluntarily pay equally for mental health given high demand.

In practice, this means a psychiatrist billing 99214 for a 25-minute med management video visit in California or New York will receive the same $150-$200 (depending on insurer and region) as an in-person visit.

Medicaid

Medicaid reimbursement tends to be lower than Medicare or commercial, but many states have enhanced behavioral health rates or care management fees. Medicaid programs in New York, California, Illinois, and Pennsylvania all reimburse telehealth at the same rate as in-person for mental health services.

For example:

• Florida Medicaid: ~$60-$80 for a 15-minute med check
• California Medi-Cal: Historically ~75% of Medicare rates, but recent investments have increased behavioral health reimbursement
• New York Medicaid: Equal reimbursement for tele-mental health (even pre-pandemic)

Cash Pay / Self-Pay

Many psychiatrists and PMHNPs on telehealth platforms opt for cash-pay models to avoid insurance overhead and maximize earnings. Typical self-pay rates for med management:

• Initial evaluation (60 min): $200-$350
• Follow-up (15-20 min): $100-$150
• Follow-up (30 min): $150-$200

Platforms like Klarity Health often operate on a pay-per-appointment model where providers set their availability and get paid per booked session. No upfront marketing spend, no monthly subscription fees — just a standard listing fee per new patient lead. This removes the financial risk of marketing yourself and guarantees ROI: you only pay when you actually see a patient.

Other Reimbursement Opportunities

Collaborative Care Model (CoCM): If you’re consulting with primary care teams, you can bill CoCM codes (99492, 99493, 99494) — Medicare pays ~$161/month for the first month per patient, ~$130/month for subsequent months. This is a monthly fee for psychiatric oversight and care coordination, separate from visit codes.

Value-based care: Some insurers offer bonuses for quality metrics (e.g., patients staying on antidepressants for 6+ months). Not widespread in psychiatry yet, but worth tracking.

The Economics: Why Klarity Health Makes Sense

Let’s talk real numbers. If you’re trying to build your own telehealth practice, here’s what patient acquisition actually costs:

DIY Marketing Reality:

• SEO: Takes 6-12 months of consistent investment (content, backlinks, technical optimization) before generating meaningful patient flow. Cost: $2,000-$5,000/month for an agency or your time + tools.
• Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. Realistic cost per booked patient: $200-$400+ when you factor in wasted ad spend, testing, and no-show rates.
• Psychology Today / Zocdoc: Monthly subscription fees ($30-$100/month) plus competition with hundreds of other providers on the same page. Zocdoc also charges per booking ($35-$100+ per lead). Total monthly cost with low lead volume: $500-$1,500+.
• Total all-in cost: If you’re running ads, paying for SEO, subscribing to directories, and managing your own scheduling/billing, you’re spending $3,000-$5,000/month with uncertain results. Early on, your cost per patient could easily be $300-$500 when you factor in all overhead, failed campaigns, and learning curve.

Klarity Health Model:

• No upfront marketing spend
• No monthly subscriptions or platform fees
• Pay only when a qualified patient books with you (standard listing fee per new patient lead)
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate EMR or video platform costs)
• Both insurance and cash-pay patient flow

The value prop is simple: instead of gambling $3,000-$5,000/month on marketing that might work, you pay a predictable fee per patient you actually see. That’s guaranteed ROI vs. the sunk cost of marketing yourself.

For providers starting out or scaling up, this removes all the risk. You control your schedule, earn competitive per-visit rates, and let Klarity handle patient acquisition. The economics just make sense — especially if you’d rather spend time treating patients than optimizing Google Ads.

State-Specific Deep Dives: What You Need to Know

California: Transitioning to Full NP Independence

Psychiatrists: Full prescriptive authority. No restrictions on telehealth prescribing (good faith exam via video is sufficient). Must check CURES (PMP) before prescribing Schedule II-IV.

PMHNPs:

• New grads: Need standardized procedures (physician protocols) for first 3 years.
• Experienced (3+ years): Can become 103 NP (Jan 2023+) and practice in group settings without direct supervision.
• Highly experienced: Can become 104 NP (Jan 2026+) and practice fully independently, including solo practice.

Telehealth: California explicitly allows teleprescribing with a video exam. Private insurance must cover at parity (AB 744). One of the most telehealth-friendly states.

Market: Over 11 million Californians live in mental health shortage areas. High demand for both MDs and NPs, especially in Central Valley and rural areas.

Texas: Restrictive for NPs, Flexible for MDs

Psychiatrists: Full authority. Can prescribe via telehealth (no prohibition on psychiatric meds). Must check PMP before controlled substances.

PMHNPs:

• Restricted practice — must have Prescriptive Authority Agreement with a Texas physician for all prescribing.
• Cannot prescribe Schedule II controlled substances in outpatient settings except very narrow cases (hospice, emergency).
• Physician supervision required indefinitely (no FPA pathway).
• Physician limited to 7 NPs at once; must meet monthly (first 3 years) then quarterly.

Telehealth: Texas allows telemedicine prescribing if standard of care met. Prohibits Schedule II prescribing for chronic pain via telehealth, but mental health treatment is allowed. No mandated parity for private insurance (though most pay equally for mental health).

Market: Huge need — 380 mental health shortage areas needing 614 psychiatrists. Ratio of 1 psychiatrist per ~8,500 residents (one of the worst in the nation). High patient volume opportunity.

Florida: Explicit Telehealth Allowance, But NPs Need Psychiatrist Supervision

Psychiatrists: Full authority. Florida explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (Statute 456.47) — one of the clearest permissions in the country.

PMHNPs:

• Restricted — psych NPs were excluded from the 2020 ‘Autonomous APRN’ law (only primary care NPs got independence).
• Must practice under physician protocol. To prescribe psychotropic controlled substances, must have a psychiatrist as the collaborating physician and be designated a ‘psychiatric nurse’ (requires 2+ years of psych experience under an MD).
• No 7-day limit on psychiatric controlled substance prescriptions (unlike other NPs prescribing opioids).

Telehealth: Very permissive for teleprescribing controlled meds for mental health. Out-of-state telehealth registration available, but out-of-state NPs cannot prescribe controlled substances to FL patients under that registration.

Market: ~7.8 million Floridians in mental health shortage areas. Ratio of 1 psychiatrist per ~9,000 residents. High demand, especially for Spanish-speaking providers and child/adolescent specialists.

New York: Experience = Independence for NPs

Psychiatrists: Full authority. New 2025 rule explicitly allows controlled substance prescribing via telehealth consistent with federal law.

PMHNPs:

• Reduced/transitional — new NPs must complete 3,600 hours (~2 years) under a collaborative agreement.
• After 3,600 hours: NPs practice independently with no written agreement or supervision required. Must attest to having a ‘collaborative relationship’ (informal referral network) but no physician oversight.
• Effectively full practice authority for experienced NPs.

Telehealth: Strong state support. All insurers must cover telehealth for mental health. Payment parity required by most insurers.

Market: High concentration of psychiatrists in NYC (~1:2,900 residents statewide), but upstate regions severely underserved. 197 mental health shortage areas needing ~230 psychiatrists. Huge opportunity for telehealth to serve upstate/rural areas.

Pennsylvania: Still Waiting on Full Practice Authority

Psychiatrists: Full authority. No telehealth restrictions.

PMHNPs:

• Reduced practice — must have collaborative agreement indefinitely (no FPA pathway yet, though legislation introduced).
• Agreement must specify which drugs NP can prescribe. Physician must countersign certain percentage of charts (often 10% every 3 months).
• Schedule II prescriptions limited to 30-day supply; physician must be notified within 24 hours.

Telehealth: No state restrictions on teleprescribing controlled substances. Medicaid and most insurers cover telepsychiatry, though no comprehensive parity statute yet.

Market: Rural central PA has significant shortages. ~65 psychiatrist vacancies to eliminate shortage areas. High NP supply (many training programs), but without FPA, some NPs leave for neighboring states with independence.

Illinois: Clear Path to NP Independence

Psychiatrists: Full authority. No telehealth restrictions.

PMHNPs:

• Reduced with pathway to FPA — must complete 4,000 hours of collaboration plus 250 hours of continuing education.
• After meeting requirements, can apply for Full Practice Authority license and prescribe independently (including controlled substances).
• Until FPA: prescriptions must be under physician delegation (physician’s name on script).

Telehealth: State law (SB 667, 2021) requires private insurers to reimburse telehealth at parity through at least 2027. Medicaid covers telepsychiatry at equal rates.

Market: High demand in rural Illinois and some urban underserved areas. ~291 practitioners needed to eliminate mental health shortages. Illinois also uniquely allows licensed clinical psychologists with specialized training to prescribe limited mental health meds under psychiatrist supervision (not common nationally).

Key Takeaways: What This Means for Your Practice

If you’re a psychiatrist:

• You can prescribe nearly all psychiatric medications via telehealth in 2026, including controlled substances, in any state where you hold a license.
• Federal waivers allow controlled substance prescribing without in-person exams through at least end of 2025 (likely to be extended).
• Check state PMPs before prescribing, document thoroughly, and ensure HIPAA-compliant video platform.
• Reimbursement is at parity with in-person visits for Medicare and most private insurance.
• High demand + favorable regulations = strong income potential, especially in underserved states like Texas and Florida.

If you’re a PMHNP:

• Your prescribing authority depends entirely on state law and your experience level.
• In full practice states (or states with transition-to-independence after X hours), you can practice and prescribe just like a psychiatrist.
• In restricted states (TX, FL, PA), you need a collaborative agreement with a physician — often a psychiatrist for psychiatric prescribing. This can be expensive and limits autonomy.
• Telehealth doesn’t change state scope-of-practice rules — if you need supervision in Texas, you need it whether you’re seeing patients in person or via video.
• Reimbursement for NPs is typically 85% of physician rates under Medicare; private insurance varies.

For both:

• Telehealth has removed geographic barriers, but you must be licensed in the state where the patient is located.
• Patient acquisition is expensive and time-consuming if you do it yourself (realistically $300-$500+ per patient when factoring in all costs and failed efforts).
• Platforms like Klarity Health solve this by providing pre-qualified patients and handling all the marketing, letting you focus on clinical work and get paid per appointment without gambling on marketing.

The big picture:Psychiatry is one of the most telehealth-friendly specialties. The combination of:

• Federal flexibility on controlled substance prescribing
• State parity laws for reimbursement
• Severe nationwide provider shortages
• High patient demand for accessible mental healthcare

…means this is one of the best times to build or scale a telepsychiatry practice. Just make sure you understand the rules in each state you practice in, stay current on DEA policy changes, and structure your practice (or platform partnerships) to handle the administrative side efficiently.

Next Steps: Join a Platform That Does the Heavy Lifting

If you’re reading this because you want to see more patients, earn more, and spend less time on marketing and admin — the math is simple.

Building your own practice means months of SEO work, thousands in ad spend, subscription fees for directories, testing what works, and dealing with no-shows from cold leads. Your total cost per acquired patient could easily hit $300-$500 when you factor in everything. And that’s after 6-12 months of investment.

Joining a platform like Klarity Health means:

• No upfront marketing costs
• No monthly platform fees
• Pre-qualified patients matched to your specialty and schedule
• Built-in telehealth infrastructure (no separate EMR or video costs)
• Pay only when you see a patient (standard listing fee per new patient lead)
• Both insurance and cash-pay patient flow
• You control your schedule and rates

The value proposition is clear: guaranteed ROI vs. gambling on marketing. You’re a provider, not a marketer. Let Klarity handle patient acquisition so you can do what you trained for — treating patients and prescribing effectively.

Explore joining Klarity’s provider network to start seeing patients without the financial risk and marketing headaches of going solo.

Sources and References

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship